Differences in tissue-remodeling potential of aortic and pulmonary heart valve interstitial cells.

Heart valve interstitial cells (VICs) appear to have a dynamic and reversible phenotype, an attribute speculated to be necessary for valve tissue remodeling during times of development and repair. Therefore, we hypothesized that the cytoskeletal (CSK) remodeling capability of the aortic and pulmonary VICs (AVICs and PVICs, respectively), which are dominated by smooth muscle alpha-actin, would exhibit unique contractile behaviors when seeded on collagen gels. Using a porcine cell source, we observed that VIC populations did not contract the gels at early time points (2 and 4 hours) as dermal fibroblasts did, but formed a central cluster of cells prior to contraction. After clustering, VICs appeared to radiate out from the center of the gels, whereas fibroblasts did not migrate but contracted the gels locally. VIC gels treated with transforming growth factor beta1 contracted the gels rapidly, revealing similar sensitivity to the cytokine. Moreover, we evaluated the initial mechanical state of the underlying CSK by comparing AVIC and PVIC stiffness with atomic force microscopy. Not only were AVICs significantly stiffer (p < 0.001) than the PVICs, but they also contracted the gels significantly more at 24 and 48 hours (p < 0.001). Taken together, these findings suggest that the AVICs are capable of inducing greater extra cellular matrix contraction, possibly manifesting in a more pronounced ability to remodel valvular tissues. Moreover, significant mechanobiological differences between AVICs and PVICs exist, and may have implications for understanding native valvular tissue remodeling. Elucidating these differences will also define important functional endpoints in the development of tissue engineering approaches for heart valve repair and replacement.

[1]  J. Humphrey,et al.  On atomic force microscopy and the constitutive behavior of living cells , 2004, Biomechanics and modeling in mechanobiology.

[2]  E Bell,et al.  Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Simon P Hoerstrup,et al.  A new source for cardiovascular tissue engineering: human bone marrow stromal cells. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  R. Markwald,et al.  Periostin regulates atrioventricular valve maturation. , 2008, Developmental biology.

[5]  M. Yacoub,et al.  Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. , 2000, The Journal of heart valve disease.

[6]  R. Levy,et al.  Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells. , 2002, The American journal of pathology.

[7]  L. Forró,et al.  Superficial and deep changes of cellular mechanical properties following cytoskeleton disassembly. , 2005, Cell motility and the cytoskeleton.

[8]  F Guilak,et al.  Viscoelastic properties of intervertebral disc cells. Identification of two biomechanically distinct cell populations. , 1999, Spine.

[9]  Frederick J Schoen,et al.  Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. , 2002, The Journal of heart valve disease.

[10]  R. Levy,et al.  Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. , 2003, The Annals of thoracic surgery.

[11]  Michael S Sacks,et al.  Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. , 2007, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[12]  W. Merryman.  Insights into (the interstitium of) degenerative aortic valve disease. , 2008, Journal of the American College of Cardiology.

[13]  K. Costa,et al.  Analysis of indentation: implications for measuring mechanical properties with atomic force microscopy. , 1999, Journal of biomechanical engineering.

[14]  Frederick J Schoen,et al.  Calcification of tissue heart valve substitutes: progress toward understanding and prevention. , 2005, The Annals of thoracic surgery.

[15]  D Guidolin,et al.  Cell composition of the human pulmonary valve: a comparative study with the aortic valve--the VESALIO Project. Vitalitate Exornatum Succedaneum Aorticum labore Ingegnoso Obtinebitur. , 2000, The Annals of thoracic surgery.

[16]  M. Sacks,et al.  Defining biomechanical endpoints for tissue engineered heart valve leaflets from native leaflet properties , 2006 .

[17]  Michael S Sacks,et al.  In-situ deformation of the aortic valve interstitial cell nucleus under diastolic loading. , 2007, Journal of biomechanical engineering.

[18]  W. D. Merryman,et al.  What modulates the aortic valve interstitial cell phenotype? , 2008, Future cardiology.

[19]  A. Gotlieb,et al.  Cell biology of valvular interstitial cells. , 1996, The Canadian journal of cardiology.

[20]  M. Simionescu,et al.  Interstitial Cells of the Heart Valves Possess Characteristics Similar to Smooth Muscle Cells , 1986, Circulation research.

[21]  F. Guilak,et al.  Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis. , 2006, American journal of physiology. Heart and circulatory physiology.

[22]  B. Hinz,et al.  Wound‐healing defect of CD18−/− mice due to a decrease in TGF‐β1 and myofibroblast differentiation , 2005, The EMBO journal.

[23]  Frederick J Schoen,et al.  Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. , 2004, The Journal of heart valve disease.

[24]  J. Mayer,et al.  Transforming Growth Factor–β1 Modulates Extracellular Matrix Production, Proliferation, and Apoptosis of Endothelial Progenitor Cells in Tissue-Engineering Scaffolds , 2006 .

[25]  Magdi H. Yacoub,et al.  The cardiac valve interstitial cell. , 2003, The international journal of biochemistry & cell biology.

[26]  Bharat Jasani,et al.  Human Wound Contraction: Collagen Organization, Fibroblasts, and Myofibroblasts , 1998, Plastic and reconstructive surgery.

[27]  R. Hetzer,et al.  Effects of Basic Fibroblast Growth Factor and Transforming Growth Factor-&bgr; on Maturation of Human Pediatric Aortic Cell Culture for Tissue Engineering of Cardiovascular Structures , 2004, ASAIO journal.

[28]  N. Nikitakis,et al.  Hsp47 a novel collagen binding serpin chaperone, autoantigen and therapeutic target. , 2005, Frontiers in bioscience : a journal and virtual library.

[29]  Edwards Je.  Calcific aortic stenosis: pathologic features. , 1961, Proceedings of the staff meetings. Mayo Clinic.

[30]  F. Guilak,et al.  Viscoelastic Properties of Intervertebral Disc Cells , 1999 .

[31]  Robert M Nerem,et al.  Porcine aortic valve interstitial cells in three-dimensional culture: comparison of phenotype with aortic smooth muscle cells. , 2004, The Journal of heart valve disease.

[32]  B L Bass,et al.  Dual structural and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast. , 1994, The Journal of surgical research.

[33]  Magdi H Yacoub,et al.  Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. , 2002, The Journal of heart valve disease.

[34]  R M Nerem,et al.  Application of the micropipette technique to the measurement of cultured porcine aortic endothelial cell viscoelastic properties. , 1990, Journal of biomechanical engineering.

[35]  N. Bulleid,et al.  Hsp47: a molecular chaperone that interacts with and stabilizes correctly‐folded procollagen , 2000, The EMBO journal.

[36]  Kristi S Anseth,et al.  Activation of valvular interstitial cells is mediated by transforming growth factor-beta1 interactions with matrix molecules. , 2005, Matrix biology : journal of the International Society for Matrix Biology.

[37]  L. Leinwand,et al.  Valvular Myofibroblast Activation by Transforming Growth Factor-&bgr;: Implications for Pathological Extracellular Matrix Remodeling in Heart Valve Disease , 2004, Circulation research.

[38]  R. Hegele,et al.  Functional Linkage between the Endoplasmic Reticulum Protein Hsp47 and Procollagen Expression in Human Vascular Smooth Muscle Cells* , 2002, The Journal of Biological Chemistry.

[39]  W. Kraus,et al.  Endothelial, cardiac muscle and skeletal muscle exhibit different viscous and elastic properties as determined by atomic force microscopy. , 2001, Journal of biomechanics.

[40]  Michael Sacks,et al.  Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves. , 2003, The Annals of thoracic surgery.